BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Devuyst O, Olinger E, Weber S, Eckardt K, Kmoch S, Rampoldi L, Bleyer AJ. Autosomal dominant tubulointerstitial kidney disease. Nat Rev Dis Primers 2019;5. [DOI: 10.1038/s41572-019-0109-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 65] [Article Influence: 11.7] [Reference Citation Analysis]
Number Citing Articles
1 Popp B, Ekici AB, Knaup KX, Schneider K, Uebe S, Park J, Bafna V, Meiselbach H, Eckardt K, Schiffer M, Reis A, Kraus C, Wiesener M. Prevalence of hereditary tubulointerstitial kidney diseases in the German Chronic Kidney Disease study. Eur J Hum Genet. [DOI: 10.1038/s41431-022-01177-9] [Reference Citation Analysis]
2 Olinger E, Schaeffer C, Kidd K, Elhassan EAE, Cheng Y, Dufour I, Schiano G, Mabillard H, Pasqualetto E, Hofmann P, Fuster DG, Kistler AD, Wilson IJ, Kmoch S, Raymond L, Robert T, Eckardt KU, Bleyer AJ Sr, Köttgen A, Conlon PJ, Wiesener M, Sayer JA, Rampoldi L, Devuyst O; Genomics England Research Consortium. An intermediate-effect size variant in UMOD confers risk for chronic kidney disease. Proc Natl Acad Sci U S A 2022;119:e2114734119. [PMID: 35947615 DOI: 10.1073/pnas.2114734119] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Econimo L, Schaeffer C, Zeni L, Cortinovis R, Alberici F, Rampoldi L, Scolari F, Izzi C. Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD): an emerging cause of genetic chronic kidney disease. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.08.012] [Reference Citation Analysis]
4 Devuyst O, Bochud M, Olinger E. UMOD and the architecture of kidney disease. Pflugers Arch 2022;474:771-81. [PMID: 35881244 DOI: 10.1007/s00424-022-02733-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lemoine H, Raud L, Foulquier F, Sayer JA, Lambert B, Olinger E, Lefèvre S, Knebelmann B, Harris PC, Trouvé P, Desprès A, Duneau G, Matignon M, Poyet A, Jourde-Chiche N, Guerrot D, Lemoine S, Seret G, Barroso-Gil M, Bingham C, Gilbert R, Le Meur Y, Audrézet MP, Cornec-Le Gall E; Genomics England Research Consortium., Genkyst Study Group. Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis. Am J Hum Genet 2022:S0002-9297(22)00266-X. [PMID: 35896117 DOI: 10.1016/j.ajhg.2022.06.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Nakayama Y, Sawa N, Suwabe T, Yamanouchi M, Ikuma D, Mizuno H, Hasegawa E, Hoshino J, Sekine A, Oba Y, Kono K, Kinowaki K, Ohashi K, Yamaguchi Y, Nozu K, Ubara Y. Kidney Histology Findings in a Patient with Autosomal Dominant Tubulointerstitial Kidney Disease Subtype Hepatocyte Nuclear Factor 1β. Intern Med 2022. [PMID: 35831109 DOI: 10.2169/internalmedicine.9364-22] [Reference Citation Analysis]
7 Lang S, Nguyen D, Bhadra P, Jung M, Helms V, Zimmermann R. Signal Peptide Features Determining the Substrate Specificities of Targeting and Translocation Components in Human ER Protein Import. Front Physiol 2022;13:833540. [DOI: 10.3389/fphys.2022.833540] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Nagasaki T, Maeda H, Taguchi K, Yanagisawa H, Nishida K, Kobayashi K, Wada N, Noguchi I, Murata R, Sakai H, Kitagishi H, Saruwatari J, Watanabe H, Otagiri M, Maruyama T. A bioinspired carbon monoxide delivery system prevents acute kidney injury and the progression to chronic kidney disease. Redox Biol 2022;54:102371. [PMID: 35763935 DOI: 10.1016/j.redox.2022.102371] [Reference Citation Analysis]
9 Gómez-garcía F, Martínez-pulleiro R, Carrera N, Allegue C, Garcia-gonzalez MA. Genetic Kidney Diseases (GKDs) Modeling Using Genome Editing Technologies. Cells 2022;11:1571. [DOI: 10.3390/cells11091571] [Reference Citation Analysis]
10 Devane J, Ott E, Olinger EG, Epting D, Decker E, Friedrich A, Bachmann N, Renschler G, Eisenberger T, Briem-Richter A, Grabhorn EF, Powell L, Wilson IJ, Rice SJ, Miles CG, Wood K, Trivedi P, Hirschfield G, Pietrobattista A, Wohler E, Mezina A, Sobreira N, Agolini E, Maggiore G, Dahmer-Heath M, Yilmaz A, Boerries M, Metzger P, Schell C, Grünewald I, Konrad M, König J, Schlevogt B, Sayer JA, Bergmann C; Genomics England Research Consortium. Progressive liver, kidney, and heart degeneration in children and adults affected by TULP3 mutations. Am J Hum Genet 2022;109:928-43. [PMID: 35397207 DOI: 10.1016/j.ajhg.2022.03.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
11 Wopperer FJ, Knaup KX, Stanzick KJ, Schneider K, Jobst-schwan T, Ekici AB, Uebe S, Wenzel A, Schliep S, Schürfeld C, Seitz R, Bernhardt W, Gödel M, Wiesener A, Popp B, Stark KJ, Gröne H, Friedrich B, Weiß M, Basic-jukic N, Schiffer M, Schröppel B, Huettel B, Beck BB, Sayer JA, Ziegler C, Büttner-herold M, Amann K, Heid IM, Reis A, Pasutto F, Wiesener MS. Diverse molecular causes of unsolved autosomal dominant tubulointerstitial kidney diseases. Kidney International 2022. [DOI: 10.1016/j.kint.2022.04.031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Marshall JL, Noel T, Wang QS, Chen H, Murray E, Subramanian A, Vernon KA, Bazua-valenti S, Liguori K, Keller K, Stickels RR, Mcbean B, Heneghan RM, Weins A, Macosko EZ, Chen F, Greka A. High-resolution Slide-seqV2 spatial transcriptomics enables discovery of disease-specific cell neighborhoods and pathways. iScience 2022;25:104097. [DOI: 10.1016/j.isci.2022.104097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Petit C, Cantarovich D, Langs V, Isidor B, Figueres L. [Genetic screening is essential in polycystic kidney disease: It is never too late!]. Nephrol Ther 2022;18:144-7. [PMID: 35101355 DOI: 10.1016/j.nephro.2021.09.002] [Reference Citation Analysis]
14 Formeck CL, Manrique-caballero CL, Gómez H, Kellum JA. Uncommon Causes of Acute Kidney Injury. Critical Care Clinics 2022;38:317-47. [DOI: 10.1016/j.ccc.2021.11.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Caliskan Y, Lee B, Whelan AM, Abualrub F, Lentine KL, Jittirat A. Evaluation of Genetic Kidney Diseases in Living Donor Kidney Transplantation: Towards Precision Genomic Medicine in Donor Risk Assessment. Curr Transpl Rep. [DOI: 10.1007/s40472-021-00340-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zhou X, Zhong X, Duan L. Integration of Artificial Intelligence And Multi-omics in Kidney Diseases. Fundamental Research 2022. [DOI: 10.1016/j.fmre.2022.01.037] [Reference Citation Analysis]
17 Joseph CB, Mariniello M, Yoshifuji A, Schiano G, Lake J, Marten J, Richmond A, Huffman JE, Campbell A, Harris SE, Troyanov S, Cocca M, Robino A, Thériault S, Eckardt K, Wuttke M, Cheng Y, Corre T, Kolcic I, Black C, Bruat V, Concas MP, Sala C, Aeschbacher S, Schaefer F, Bergmann S, Campbell H, Olden M, Polasek O, Porteous DJ, Deary IJ, Madore F, Awadalla P, Girotto G, Ulivi S, Conen D, Wuehl E, Olinger E, Wilson JF, Bochud M, Köttgen A, Hayward C, Devuyst O. Meta-GWAS Reveals Novel Genetic Variants Associated with Urinary Excretion of Uromodulin. JASN 2022;33:511-29. [DOI: 10.1681/asn.2021040491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Zhao S, Mo X, Wen Z, Ren L, Chen Z, Lin W, Wang Q, Min S, Chen B. Comprehensive bioinformatics analysis reveals the hub genes and pathways associated with multiple myeloma. Hematology 2022;27:280-92. [PMID: 35192775 DOI: 10.1080/16078454.2022.2040123] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Sicking M, Živná M, Bhadra P, Barešová V, Tirincsi A, Hadzibeganovic D, Hodaňová K, Vyleťal P, Sovová J, Jedličková I, Jung M, Bell T, Helms V, Bleyer AJ, Kmoch S, Cavalié A, Lang S. Phenylbutyrate rescues the transport defect of the Sec61α mutations V67G and T185A for renin. Life Sci Alliance 2022;5:e202101150. [PMID: 35064074 DOI: 10.26508/lsa.202101150] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Olinger E, Wilson I, Devuyst O, Sayer JA. Translational Science Kidney traits on repeat - the role of MUC1 VNTR. Kidney Int 2022:S0085-2538(22)00019-9. [PMID: 35031326 DOI: 10.1016/j.kint.2021.12.026] [Reference Citation Analysis]
21 Senum SR, Li YSM, Benson KA, Joli G, Olinger E, Lavu S, Madsen CD, Gregory AV, Neatu R, Kline TL, Audrézet MP, Outeda P, Nau CB, Meijer E, Ali H, Steinman TI, Mrug M, Phelan PJ, Watnick TJ, Peters DJM, Ong ACM, Conlon PJ, Perrone RD, Cornec-Le Gall E, Hogan MC, Torres VE, Sayer JA, Harris PC; Genomics England Research Consortium, the HALT PKD, CRISP, DIPAK, ADPKD Modifier, and TAME PKD studies. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype. Am J Hum Genet 2022;109:136-56. [PMID: 34890546 DOI: 10.1016/j.ajhg.2021.11.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
22 Okada E, Morisada N, Horinouchi T, Fujii H, Tsuji T, Miura M, Katori H, Kitagawa M, Morozumi K, Toriyama T, Nakamura Y, Nishikomori R, Nagai S, Kondo A, Aoto Y, Ishiko S, Rossanti R, Sakakibara N, Nagano C, Yamamura T, Ishimori S, Usui J, Yamagata K, Iijima K, Imasawa T, Nozu K. Detecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2021.12.037] [Reference Citation Analysis]
23 Singh P, Harris PC, Sas DJ, Lieske JC. The genetics of kidney stone disease and nephrocalcinosis. Nat Rev Nephrol 2021. [PMID: 34907378 DOI: 10.1038/s41581-021-00513-4] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
24 Claverie-Martin F, Perdomo-Ramirez A, Garcia-Nieto V. Hereditary kidney diseases associated with hypomagnesemia. Kidney Res Clin Pract 2021. [PMID: 34784661 DOI: 10.23876/j.krcp.21.112] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Nowak PJ, Forycka J, Cegielska N, Harendarz K, Wągrowska-Danilewicz M, Danilewicz M, Płoszaj T, Borowiec M, Wlazeł R, Nowicki M. Glucocorticoids Induce Partial Remission of Focal Segmental Glomerulosclerosis but Not Interstitial Nephritis in COVID-19 Acute Kidney Injury in an APOL1 Low-Risk Genotype White Patient. Am J Case Rep 2021;22:e933462. [PMID: 34727096 DOI: 10.12659/AJCR.933462] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Leask MP, Merriman TR. The genetic basis of urate control and gout: Insights into molecular pathogenesis from follow-up study of genome-wide association study loci. Best Pract Res Clin Rheumatol 2021;:101721. [PMID: 34732286 DOI: 10.1016/j.berh.2021.101721] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
27 Gusev E, Solomatina L, Zhuravleva Y, Sarapultsev A. The Pathogenesis of End-Stage Renal Disease from the Standpoint of the Theory of General Pathological Processes of Inflammation. Int J Mol Sci 2021;22:11453. [PMID: 34768884 DOI: 10.3390/ijms222111453] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Nuñez-Gonzalez L, Carrera N, Garcia-Gonzalez MA. Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Bartter and Gitelman Syndromes: A Primer for Clinicians. Int J Mol Sci 2021;22:11414. [PMID: 34768847 DOI: 10.3390/ijms222111414] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
29 Ponte B, Sadler MC, Olinger E, Vollenweider P, Bochud M, Padmanabhan S, Hayward C, Kutalik Z, Devuyst O. Mendelian randomization to assess causality between uromodulin, blood pressure and chronic kidney disease. Kidney Int 2021;100:1282-91. [PMID: 34634361 DOI: 10.1016/j.kint.2021.08.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
30 Teng MS, Wu S, Hsu LA, Chou HH, Ko YL. Pleiotropic Effects of Functional MUC1 Variants on Cardiometabolic, Renal, and Hematological Traits in the Taiwanese Population. Int J Mol Sci 2021;22:10641. [PMID: 34638981 DOI: 10.3390/ijms221910641] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Yan MT, Chao CT, Lin SH. Chronic Kidney Disease: Strategies to Retard Progression. Int J Mol Sci 2021;22:10084. [PMID: 34576247 DOI: 10.3390/ijms221810084] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
32 Mabillard H, Sayer JA, Olinger E. Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease. Nephrol Dial Transplant 2021:gfab268. [PMID: 34519781 DOI: 10.1093/ndt/gfab268] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Viaño Nogueira P, de Lucas Collantes C, Ortiz Cabrera V, Urquía Renke A, Aparicio López C. UMOD-related autosomal dominant tubulointerstitial kidney disease: An unfavourable novel mutation. Nefrologia (Engl Ed) 2021:S0211-6995(21)00155-7. [PMID: 34503864 DOI: 10.1016/j.nefro.2021.07.007] [Reference Citation Analysis]
34 Pepper RJ, Trompeter RS. The causes and consequences of paediatric kidney disease on adult nephrology care. Pediatr Nephrol 2021. [PMID: 34389906 DOI: 10.1007/s00467-021-05182-w] [Reference Citation Analysis]
35 Rubin JD, Barry MA. Improving Molecular Therapy in the Kidney. Mol Diagn Ther 2020;24:375-96. [PMID: 32323260 DOI: 10.1007/s40291-020-00467-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 LaFavers KA, El-Achkar TM. Autosomal dominant tubulointerstitial kidney disease: a new tool to guide genetic testing. Kidney Int 2020;98:549-52. [PMID: 32828237 DOI: 10.1016/j.kint.2020.05.046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Vylet'al P, Kidd K, Ainsworth HC, Springer D, Vrbacká A, Přistoupilová A, Hughey RP, Alper SL, Lennon N, Harrison S, Harden M, Robins V, Taylor A, Martin L, Howard K, Bitar I, Langefeld CD, Barešová V, Hartmannová H, Hodaňová K, Zima T, Živná M, Kmoch S, Bleyer AJ. Plasma Mucin-1 (CA15-3) Levels in Autosomal Dominant Tubulointerstitial Kidney Disease due to MUC1 Mutations. Am J Nephrol 2021;52:378-87. [PMID: 34098564 DOI: 10.1159/000515810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Bleyer AJ, Wolf MT, Kidd KO, Zivna M, Kmoch S. Autosomal dominant tubulointerstitial kidney disease: more than just HNF1β. Pediatr Nephrol 2021. [PMID: 34021396 DOI: 10.1007/s00467-021-05118-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
39 Stokman MF, Saunier S, Benmerah A. Renal Ciliopathies: Sorting Out Therapeutic Approaches for Nephronophthisis. Front Cell Dev Biol 2021;9:653138. [PMID: 34055783 DOI: 10.3389/fcell.2021.653138] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
40 Barroso-Gil M, Olinger E, Sayer JA. Molecular genetics of renal ciliopathies. Biochem Soc Trans 2021;49:1205-20. [PMID: 33960378 DOI: 10.1042/BST20200791] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
41 Niborski LL, Paces-Fessy M, Ricci P, Bourgeois A, Magalhães P, Kuzma-Kuzniarska M, Lesaulnier C, Reczko M, Declercq E, Zürbig P, Doucet A, Umbhauer M, Cereghini S. Hnf1b haploinsufficiency differentially affects developmental target genes in a new renal cysts and diabetes mouse model. Dis Model Mech 2021;14:dmm047498. [PMID: 33737325 DOI: 10.1242/dmm.047498] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
42 Sicking M, Lang S, Bochen F, Roos A, Drenth JPH, Zakaria M, Zimmermann R, Linxweiler M. Complexity and Specificity of Sec61-Channelopathies: Human Diseases Affecting Gating of the Sec61 Complex. Cells 2021;10:1036. [PMID: 33925740 DOI: 10.3390/cells10051036] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
43 Vargas-Poussou R. Pathophysiological aspects of the thick ascending limb and novel genetic defects: HELIX syndrome and transient antenatal Bartter syndrome. Pediatr Nephrol 2021. [PMID: 33733301 DOI: 10.1007/s00467-021-05019-6] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
44 Chen L, Chou CL, Knepper MA. A Comprehensive Map of mRNAs and Their Isoforms across All 14 Renal Tubule Segments of Mouse. J Am Soc Nephrol 2021:ASN. [PMID: 33769951 DOI: 10.1681/ASN.2020101406] [Cited by in Crossref: 7] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
45 Oba Y, Sawa N, Mizuno H, Hoshino J, Kinowaki K, Ohashi K, Morisada N, Iijima K, Yamaguchi Y, Ubara Y. Autosomal Dominant Tubulointerstitial Kidney Disease HNF1B With Maturity-Onset Diabetes of the Young: A Case Report With Kidney Biopsy. Kidney Med 2021;3:278-81. [PMID: 33851123 DOI: 10.1016/j.xkme.2020.10.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Dvela-Levitt M, Shaw JL, Greka A. A Rare Kidney Disease To Cure Them All? Towards Mechanism-Based Therapies for Proteinopathies. Trends Mol Med 2021;27:394-409. [PMID: 33341352 DOI: 10.1016/j.molmed.2020.11.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Zacchia M, Blanco FDV, Torella A, Raucci R, Blasio G, Onore ME, Marchese E, Trepiccione F, Vitagliano C, Iorio VD, Alessandra P, Simonelli F, Nigro V, Capasso G, Viggiano D. Urine concentrating defect as presenting sign of progressive renal failure in Bardet-Biedl syndrome patients. Clin Kidney J 2021;14:1545-51. [PMID: 34084454 DOI: 10.1093/ckj/sfaa182] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
48 Schaeffer C, Olinger E. Clinical and genetic spectra of kidney disease caused by REN mutations. Kidney Int 2020;98:1397-400. [PMID: 33276865 DOI: 10.1016/j.kint.2020.08.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Espino-Hernández M, Palma Milla C, Vara-Martín J, González-Granado LI. De novo SEC61A1 mutation in autosomal dominant tubulo-interstitial kidney disease: Phenotype expansion and review of literature. J Paediatr Child Health 2021;57:1305-7. [PMID: 33185949 DOI: 10.1111/jpc.15148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
50 Izzi C, Dordoni C, Econimo L, Delbarba E, Grati FR, Martin E, Mazza C, Savoldi G, Rampoldi L, Alberici F, Scolari F. Variable Expressivity of HNF1B Nephropathy, From Renal Cysts and Diabetes to Medullary Sponge Kidney Through Tubulo-interstitial Kidney Disease. Kidney Int Rep 2020;5:2341-50. [PMID: 33305128 DOI: 10.1016/j.ekir.2020.09.042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
51 Wang Y, Liu H, He Q, Yi Z, Li Y, Dang X. A novel likely pathogenic variant in the UMOD gene in a family with autosomal dominant tubulointerstitial kidney disease: a case report. BMC Nephrol 2020;21:368. [PMID: 32847529 DOI: 10.1186/s12882-020-02022-1] [Reference Citation Analysis]
52 Groopman EE, Povysil G, Goldstein DB, Gharavi AG. Rare genetic causes of complex kidney and urological diseases. Nat Rev Nephrol 2020;16:641-56. [PMID: 32807983 DOI: 10.1038/s41581-020-0325-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
53 Stevenson M, Pagnamenta AT, Reichart S, Philpott C, Lines KE, Gorvin CM, Lhotta K, Taylor JC, Thakker RV; OxClinWGS. Whole genome sequence analysis identifies a PAX2 mutation to establish a correct diagnosis for a syndromic form of hyperuricemia. Am J Med Genet A 2020;182:2521-8. [PMID: 32776440 DOI: 10.1002/ajmg.a.61814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Huynh VT, Audrézet M, Sayer JA, Ong AC, Lefevre S, Le Brun V, Després A, Senum SR, Chebib FT, Barroso-gil M, Patel C, Mallett AJ, Goel H, Mallawaarachchi AC, Van Eerde AM, Ponlot E, Kribs M, Le Meur Y, Harris PC, Cornec-le Gall E. Clinical spectrum, prognosis and estimated prevalence of DNAJB11-kidney disease. Kidney International 2020;98:476-87. [DOI: 10.1016/j.kint.2020.02.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
55 Živná M, Kidd K, Zaidan M, Vyleťal P, Barešová V, Hodaňová K, Sovová J, Hartmannová H, Votruba M, Trešlová H, Jedličková I, Sikora J, Hůlková H, Robins V, Hnízda A, Živný J, Papagregoriou G, Mesnard L, Beck BB, Wenzel A, Tory K, Häeffner K, Wolf MTF, Bleyer ME, Sayer JA, Ong ACM, Balogh L, Jakubowska A, Łaszkiewicz A, Clissold R, Shaw-Smith C, Munshi R, Haws RM, Izzi C, Capelli I, Santostefano M, Graziano C, Scolari F, Sussman A, Trachtman H, Decramer S, Matignon M, Grimbert P, Shoemaker LR, Stavrou C, Abdelwahed M, Belghith N, Sinclair M, Claes K, Kopel T, Moe S, Deltas C, Knebelmann B, Rampoldi L, Kmoch S, Bleyer AJ. An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes. Kidney Int 2020;98:1589-604. [PMID: 32750457 DOI: 10.1016/j.kint.2020.06.041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
56 Devuyst O, Pei Y. Next-generation sequencing for detection of somatic mosaicism in autosomal dominant polycystic kidney disease. Kidney Int 2020;97:261-3. [PMID: 31980075 DOI: 10.1016/j.kint.2019.11.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Kidd K, Vylet'al P, Schaeffer C, Olinger E, Živná M, Hodaňová K, Robins V, Johnson E, Taylor A, Martin L, Izzi C, Jorge SC, Calado J, Torres RJ, Lhotta K, Steubl D, Gale DP, Gast C, Gombos E, Ainsworth HC, Chen YM, Almeida JR, de Souza CF, Silveira C, Raposeiro R, Weller N, Conlon PJ, Murray SL, Benson KA, Cavalleri GL, Votruba M, Vrbacká A, Amoroso A, Gianchino D, Caridi G, Ghiggeri GM, Divers J, Scolari F, Devuyst O, Rampoldi L, Kmoch S, Bleyer AJ. Genetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutations. Kidney Int Rep 2020;5:1472-85. [PMID: 32954071 DOI: 10.1016/j.ekir.2020.06.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
58 Molinari E, Sayer JA. Disease Modeling To Understand the Pathomechanisms of Human Genetic Kidney Disorders. Clin J Am Soc Nephrol 2020;15:855-72. [PMID: 32139361 DOI: 10.2215/CJN.08890719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Wang GQ, Rui HL, Dong HR, Sun LJ, Yang M, Wang YY, Ye N, Zhao ZR, Liu XJ, Xu XY, Chen YP, Cheng H. SMRT sequencing revealed to be an effective method for ADTKD-MUC1 diagnosis through follow-up analysis of a Chinese family. Sci Rep 2020;10:8616. [PMID: 32451462 DOI: 10.1038/s41598-020-65491-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
60 Olinger E, Hofmann P, Kidd K, Dufour I, Belge H, Schaeffer C, Kipp A, Bonny O, Deltas C, Demoulin N, Fehr T, Fuster DG, Gale DP, Goffin E, Hodaňová K, Huynh-Do U, Kistler A, Morelle J, Papagregoriou G, Pirson Y, Sandford R, Sayer JA, Torra R, Venzin C, Venzin R, Vogt B, Živná M, Greka A, Dahan K, Rampoldi L, Kmoch S, Bleyer AJ Sr, Devuyst O. Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1. Kidney Int 2020;98:717-31. [PMID: 32450155 DOI: 10.1016/j.kint.2020.04.038] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
61 Bignon Y, Poindessous V, Lazareth H, Passet B, Vilotte JL, Djouadi F, Mouillet-Richard S, Pallet N. The cellular prion protein is a stress protein secreted by renal tubular cells and a urinary marker of kidney injury. Cell Death Dis 2020;11:243. [PMID: 32303684 DOI: 10.1038/s41419-020-2430-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
62 Hu J, Harris PC. Regulation of polycystin expression, maturation and trafficking. Cell Signal 2020;72:109630. [PMID: 32275942 DOI: 10.1016/j.cellsig.2020.109630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
63 Shao A, Chan SC, Igarashi P. Role of transcription factor hepatocyte nuclear factor-1β in polycystic kidney disease. Cell Signal 2020;71:109568. [PMID: 32068086 DOI: 10.1016/j.cellsig.2020.109568] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
64 Cormican S, Kennedy C, Connaughton DM, O'Kelly P, Murray S, Živná M, Kmoch S, Fennelly NK, Benson KA, Conlon ET, Cavalleri GL, Foley C, Doyle B, Dorman A, Little MA, Lavin P, Kidd K, Bleyer AJ, Conlon PJ. Renal transplant outcomes in patients with autosomal dominant tubulointerstitial kidney disease. Clin Transplant 2020;34:e13783. [PMID: 31958169 DOI: 10.1111/ctr.13783] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Schiano G, Glaudemans B, Olinger E, Goelz N, Müller M, Loffing-Cueni D, Deschenes G, Loffing J, Devuyst O. The Urinary Excretion of Uromodulin is Regulated by the Potassium Channel ROMK. Sci Rep 2019;9:19517. [PMID: 31863061 DOI: 10.1038/s41598-019-55771-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]